Regis Healthcare Limited (REG.AX)
| Previous close | 4.1400 |
| Open | 4.1300 |
| Bid | 4.0700 x 0 |
| Ask | 4.1200 x 0 |
| Day's range | 4.0600 - 4.1600 |
| 52-week range | 2.1100 - 4.5400 |
| Volume | |
| Avg. volume | 698,110 |
| Market cap | 1.228B |
| Beta (5Y monthly) | 1.47 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.13 (3.08%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Simply Wall St.
Unveiling Three ASX Stocks Estimated To Trade Below Their Fair Value
The Australian stock market has shown robust performance, with a 3.0% increase over the last week and a 10% rise over the past year, coupled with an anticipated annual earnings growth of 14%. In this context, identifying stocks that trade below their fair value can offer investors potential opportunities for growth in a flourishing market environment.
- Simply Wall St.
Top 3 ASX Stocks Estimated To Be Trading Below Intrinsic Value In July 2024
Amidst a fluctuating Australian market, influenced by the Reserve Bank of Australia's contemplation of interest rate hikes, investors are keenly observing opportunities where value might be hidden. In such a climate, identifying stocks trading below their intrinsic value could provide prudent investment avenues.
- Simply Wall St.
ASX Stocks Estimated To Be Below Value In June 2024
Amidst fluctuations in the ASX200 and sector-specific downturns, particularly in IT and Energy, investors are keenly observing market movements for potential opportunities. In such an environment, identifying undervalued stocks becomes crucial as it might offer a strategic advantage in navigating through these challenging market conditions.
